Has the Amazon Prime of Cancer Genomic Profiling Arrived?

Posted by Pavankumar Anne on January 9, 2020

Jim Adelizzi co-wrote this blog post with Pavankumar Anne. A version of this blog post was originally published on ZS's oncology blog, First Line.

A quarter of a century ago, Jeff Bezos developed a website to sell books online. Now, Amazon has reshaped the retail market by changing people’s expectations for online shopping and the speed of shipping via one-day, two-day and even one-hour shipping for Amazon Prime members. Similarly, precision medicine in oncology is in the midst of an Amazon-like revolution, too. Innovations in next-generation sequencing (NGS) technology have enabled advances in cancer genomic profiling by increasing the speed, accuracy and affordability of sequencing.


>
Read More

Innovation Is Healthcare’s New Normal

Posted by Pratap Khedkar on October 17, 2019

This blog post was originally published on ZS's pharma blog, The Active Ingredient.

Sometimes it’s hard to keep in mind that healthcare was once considered a stodgy, conservative industry—at least by outsiders. Advances in care development and delivery happened, but the healthcare experience was generally the same as it had been decades before, as were the business models leveraged across the healthcare landscape. We’d grown, maybe not comfortable with, but accepting of the status quo.


>
Read More

Times Are Changing: Making Way for Marketing

Posted by Matt Singer on October 4, 2019

I had the pleasure of facilitating a panel this week at The Medtech Conference, put on by Advamed. We discussed how more empowered marketing teams can drive success for medtech companies. Many thanks to our esteemed medtech marketing panelists: George Parr (CMO of Becton Dickinson), Rob Clark (chief communications officer of Medtronic), Randy Pritchard (senior vice president of marketing at Roche Diagnostics) and Rajit Kamal (vice president, global franchise leader of knees at Johnson & Johnson Medical Devices).


>
Read More

Streamlining Your Portfolio Can Actually Improve Profitability. Here’s How.

Posted by Matt Singer on September 23, 2019

Many medtech companies pride themselves on their broad product portfolio and ability to address a variety of customer needs. However, if a portfolio becomes too bloated, they can incur huge costs to “keep the lights on,” create complexity for customers and sales reps, distract resources from innovation, and create potential external risk for the company and its executives.


>
Read More

Assessing the Future of Robotics in Medtech

Posted by Andy Kach on August 14, 2019

This article was originally published in Medtech Insight.

Every medical device company—in and out of the surgical business—and many other tech companies are deep in the war of surgical robotics and digital solutions.


>
Read More